Profund Advisors’s Corcept Therapeutics CORT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$595K Sell
8,101
-3,000
-27% -$220K 0.02% 418
2025
Q1
$1.27M Sell
11,101
-157
-1% -$17.9K 0.06% 251
2024
Q4
$567K Sell
11,258
-5,286
-32% -$266K 0.02% 451
2024
Q3
$766K Sell
16,544
-777
-4% -$36K 0.03% 391
2024
Q2
$563K Sell
17,321
-6,260
-27% -$203K 0.02% 466
2024
Q1
$594K Buy
23,581
+7,427
+46% +$187K 0.02% 521
2023
Q4
$525K Buy
16,154
+4,697
+41% +$153K 0.02% 499
2023
Q3
$312K Sell
11,457
-2,792
-20% -$76.1K 0.02% 651
2023
Q2
$317K Sell
14,249
-762
-5% -$17K 0.02% 693
2023
Q1
$325K Buy
15,011
+2,650
+21% +$57.4K 0.02% 677
2022
Q4
$251K Sell
12,361
-553
-4% -$11.2K 0.02% 756
2022
Q3
$331K Sell
12,914
-880
-6% -$22.6K 0.02% 538
2022
Q2
$328K Sell
13,794
-1,760
-11% -$41.9K 0.02% 586
2022
Q1
$350K Buy
15,554
+99
+0.6% +$2.23K 0.01% 804
2021
Q4
$306K Sell
15,455
-1,030
-6% -$20.4K 0.01% 969
2021
Q3
$324K Sell
16,485
-2,417
-13% -$47.5K 0.01% 892
2021
Q2
$417K Buy
18,902
+1,083
+6% +$23.9K 0.01% 802
2021
Q1
$424K Sell
17,819
-1,526
-8% -$36.3K 0.02% 705
2020
Q4
$506K Buy
19,345
+3,730
+24% +$97.6K 0.02% 537
2020
Q3
$272K Sell
15,615
-1,236
-7% -$21.5K 0.01% 724
2020
Q2
$283K Buy
16,851
+2,670
+19% +$44.8K 0.02% 636
2020
Q1
$169K Sell
14,181
-3,371
-19% -$40.2K 0.01% 665
2019
Q4
$212K Buy
17,552
+1,153
+7% +$13.9K 0.01% 1141
2019
Q3
$232K Sell
16,399
-1,579
-9% -$22.3K 0.01% 1093
2019
Q2
$200K Sell
17,978
-1,219
-6% -$13.6K 0.01% 1143
2019
Q1
$225K Sell
19,197
-9,765
-34% -$114K 0.01% 1076
2018
Q4
$387K Sell
28,962
-14,502
-33% -$194K 0.02% 599
2018
Q3
$609K Buy
43,464
+22,248
+105% +$312K 0.02% 648
2018
Q2
$334K Buy
21,216
+1,885
+10% +$29.7K 0.01% 1089
2018
Q1
$318K Buy
19,331
+5,114
+36% +$84.1K 0.01% 1097
2017
Q4
$257K Buy
+14,217
New +$257K 0.01% 1227
2014
Q2
Sell
-10,200
Closed -$44K 1567
2014
Q1
$44K Buy
+10,200
New +$44K ﹤0.01% 1573